All In Biotech

Drug Trial Radar · NCT03526549

Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)

A Phase 3b, Open-Label, Long-Term Study to Evaluate the Safety and Temporal Pattern of Response of EN3835 in the Treatment of Edematous Fibrosclerotic Panniculopathy

Last checked: Nov 19, 2026Latest source record: Sep 8, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

483

Actual

Start

Apr 26, 2018

Primary completion

Oct 8, 2021

Study completion Oct 8, 2021

Sponsor

Sponsor type
Industry
First posted
May 16, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 3b, Open-Label Extension Study to evaluate safety and how long response of EN3835 (Collagenase Clostridium Histolyticum \[CCH\]-aaes) lasts in the treatment of Cellulite.

Conditions

  • Edematous Fibrosclerotic Panniculopathy
  • Cellulite

Interventions

  • CCH-aaesBiological

    Administered to participants who qualified for, and opted for, retreatment.

  • ObservationOther

    No treatment administered during 180 days of observation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-emergent Adverse Events (TEAEs)Time frame: Up to Day 1080
  2. Percentage of Participants Who Were Seropositive for Anti-Drug Antibodies (ADAs) After CCH-aaes TreatmentTime frame: From Day 180 (Open-label Phase) up to Day 1080

Locations

42 sites in 1 country. Site status is shown where the registry gives one.

  • Endo Clinical Trial Site #3

    Glendale, Arizona

  • Endo Clinical Trial Site #11

    Scottsdale, Arizona

  • Endo Clinical Trial Site #41

    North Little Rock, Arkansas

  • Endo Clinical Trial Site #14

    Encinitas, California

  • Endo Clinical Trial Site #9

    Long Beach, California

  • Endo Clinical Trial Site #35

    Murrieta, California

  • Endo Clinical Trial Site #42

    Newport Beach, California

  • Endo Clinical Trial Site #17

    Oceanside, California

  • Endo Clinical Trial Site #39

    San Diego, California

  • Endo Clinical Trial Site #23

    Greenwood Village, Colorado

  • Endo Clinical Trial Site #38

    Boca Raton, Florida

  • Endo Clinical Trial Site #8

    Coral Gables, Florida

  • Endo Clinical Trial Site #40

    Largo, Florida

  • Endo Clinical Trial Site #27

    Miami, Florida

  • Endo Clinical Trial Site #36

    Miami, Florida

  • Endo Clinical Trial Site #20

    Snellville, Georgia

  • Endo Clinical Trial Site #19

    Meridian, Idaho

  • Endo Clinical Trial Site #34

    Chicago, Illinois

  • Endo Clinical Trial Site #30

    Indianapolis, Indiana

  • Endo Clinical Trial Site #16

    Metairie, Louisiana

  • Endo Clinical Trial Site #10

    New Orleans, Louisiana

  • Endo Clinical Trial Site #25

    New Orleans, Louisiana

  • Endo Clinical Trial Site #33

    Quincy, Massachusetts

  • Endo Clinical Trial Site #18

    Washington, Missouri

  • Endo Clinical Trial Site #4

    Omaha, Nebraska

  • Endo Clinical Trial Site #24

    Mount Kisco, New York

  • Endo Clinical Trial Site #32

    New York, New York

  • Endo Clinical Trial Site #12

    New York, New York

  • Endo Clinical Trial Site #15

    New York, New York

  • Endo Clinical Trial Site #29

    New York, New York

  • Endo Clinical Trial Site #26

    Cincinnati, Ohio

  • Endo Clinical Trial Site #5

    Nashville, Tennessee

  • Endo Clinical Trial Site #22

    Austin, Texas

  • Endo Clinical Trial Site #6

    Beaumont, Texas

  • Endo Clinical Trial Site #13

    Houston, Texas

  • Endo Clinical Trial Site #7

    Houston, Texas

  • Endo Clinical Trial Site #28

    Pflugerville, Texas

  • Endo Clinical Trial Site #21

    San Antonio, Texas

  • Endo Clinical Trial Site #37

    Sugar Land, Texas

  • Endo Clinical Trial Site #31

    Salt Lake City, Utah

Showing 40 of 42 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.